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cytoskeleton, thus stabilizing the muscle as it alternatelyMartin E. Hemler
Dana-Farber Cancer Institute contracts and relaxes. In particular, the a-dystrogly-
can protein binds to the extracellular matrix proteinBoston, Massachusetts 02115
laminin-2, while b-dystroglycan spans the membrane
and links directly to dystrophin, and other cytoskeletal
proteins in the dystrophin family (Figure 1A). These inDystroglycan, a central component of the skeletal mus-
turn link to other cytoskeletal and signaling proteinscle dystrophin glycoprotein complex (DGC), plays a key
(e.g., syntrophin proteins), and to the actin cytoskeleton.role in maintaining normal muscle function. Initially
Also, muscle dystroglycan and dystrophin are part of aencoded as a single protein, dystroglycan undergoes
larger complex that contains the four 35±50 kDa sarco-posttranslational cleavage to form a-dystroglycan, a
glycan proteins (a, b, g, d), as well as the 25 kDa sarcos-peripheral membrane protein, and b-dystroglycan, a
pan protein, each of uncertain function. The sarcogly-transmembrane protein. Dystroglycan is currently best
cans each contain one transmembrane domain, whileknown for its functions in muscle. However, dystrogly-
sarcospan contains four transmembrane domains. It iscan is also widely expressed on nonmuscle cells, and
not yet known if sarcospan or any of the sarcoglycansits functions there have been less well studied. Three
directly interact with dystroglycan. Mutations in dys-new functions for dystroglycan have now emerged, each
trophin, sarcoglycans, and laminin-2 each give rise toinvolving dystroglycan on nonmuscle cells. As indicated
different forms of muscular dystrophy (Campbell, 1995).by Henry and Campbell (1998), dystroglycan may be
However, mutations in dystroglycan have not been as-required for cell-driven assembly of extracellular matrix
sociated with muscular dystrophy, presumably becauseproteins (e.g., laminin-1, collagen IV, and perlecan) into
it has many critical functions in nonmuscle cells (seebasement membranes. In another study, Cao et al.
below).(1998) found that dystroglycan is bound directly by sev-
In muscle, dystroglycan also plays a specialized role ineral types of arenaviruses and is necessary for virus
neuromuscular junctions (Figure 1B). Here dystroglycaninfection. Moreover, Rambukkana et al. (1998) have
may bind to agrin, a heparan sulfate proteoglycan in-demonstrated that Mycobacterium leprae, complexed
volved in synaptic specialization during neuromuscularwith laminin-2, utilizes a-dystroglycan as a target for
junction development. Agrin contains three laminin-typeentry into peripheral nerve Schwann cells.
G (LG) domains at its COOH terminus and uses theseThe role of dystroglycan in skeletal muscle cells can
to bind to dystroglycan, while the amino-terminal endbe briefly summarized as follows. In muscle fibers, the
of agrin binds to various forms of laminin, includingassociated a and b subunits of dystroglycan play a cen-
tral role in linking the extracellular matrix with the actin laminin-1, laminin-2, and laminin-4 (Denzer et al., 1998).
Figure 1. Dystroglycan in Skeletal Muscle
(A) Dystroglycan (DG) spans the sarcolemma, linking extracellular laminin-2 with the cytoskeleton.
(B) Dystroglycan in synaptic basal lamina of neuromuscular junctions binds to extracellular laminin-2 and agrin, and intracellular utrophin.
Association with the rapsyn protein may provide a link to the acetylcholine receptor (AChR). Relevant O-linked glycosylation sites are indicated
on a-dystroglycan.
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Figure 2. Dystroglycan in Nonmuscle Cells
(A) Dystroglycan in epithelial cells binds to laminin-1, and perlecan and supports basement membrane assembly. An isoform of agrin also
binds tightly to dystroglycan in lung, kidney, and brain.
(B) On a variety of cell types, dystroglycan binds to arenaviruses.
(C) Dystroglycan binds, via laminin-2, to M. leprae±laminin-2 complexes.
Laminin itself also binds to dystroglycan at neuromuscu- organized basement membrane staining in wild type
and heterozygous embryoid bodies, but diffuse, patchylar junctions and helps to facilitate AChR clustering. It
was originally thought that dystroglycan might help to staining in the dystroglycan-null embryoid bodies. Elec-
tron microscopy confirmed that basement membranesinitiate acetylcholine receptor (AChR) clustering, but
now it is seen to act downstream to consolidate and were absent from dystroglycan-null embryoid bodies.
Also, when soluble laminin-1 was added to normal ESmaintain AChR clustering (Montanaro et al., 1998). In this
regard, the cytoplasmic tail of b-dystroglycan contains a cells, it became organized into clusters that closely colo-
calized with dystroglycan. In contrast, dystroglycan-nullbinding site for rapsyn, a protein that may link dystrophin
to the AChR (Cartaud et al., 1998). Although not shown ES cells failed to organize soluble laminin-1 into clusters.
Henry and Campbell then used adenovirus infection toin Figure 1B, synaptic dystroglycan may bind and colo-
calize with perlecan, another heparan sulfate proteogly- reconstitute null ES cells and embryoid bodies with dys-
troglycan. In the process they regained laminin-1 andcan containing laminin-type LG domains (Peng et al.,
1998). Compared to dystroglycan complexes in muscle collagen IV localization into embryoid body basement
membranes, and ES cells regained capability to orga-fibers, those in synapses are distinct, as dystrophin is
replaced by its homolog, utrophin (Figure 1B). nize soluble laminin-1 into clusters. Notably, the soluble
laminin-1 clustered by wild-type ES cells was addedThe broad distribution of dystroglycan in a great many
fetal and adult nonmuscle tissues has been summarized at a dose well below that required for laminin-1 self-
assembly. The extent to which this dystroglycan-drivenby Durbeej et al. (1998). Importantly, there is abundant
dystroglycan present on the basal side of most epithelial laminin clustering resembles assembly of a basement
membrane laminin network is not clear. Nonetheless,cells. Deletion of the dystroglycan gene provided an
initial clue regarding the potential function of this non- these results suggest that the capacity of basement
membrane components to self-assemble (Timpl andmuscle dystroglycan. Dystroglycan-null mice exhibited
gross abnormalities early in embryogenesis (day 6.5). Brown, 1996) may be enhanced and controlled by cell
surface dystroglycan nucleation sites. Also, this type ofAn early defect was a severe disruption of Reichert's
membrane, one of the earliest basement membranes mechanism could help to explain how cells may assem-
ble basement membranes while utilizing componentsformed during development (Williamson et al., 1997).
This apparent dystroglycan requirement for develop- synthesized elsewhere by other cells.
Although the authors emphasize that dystroglycanment of Reichert's membrane, coupled with the expres-
sion of dystroglycan on the basal side of many epithelia, binding to laminin-1 is a likely initiator of basement mem-
brane organization, it should be noted that perlecan alsoled to the hypothesis that dystroglycan could play a
critical role during the assembly of basement mem- contains LG domains and binds to dystroglycan, with
an affinity that may be stronger than that of laminin-1branes. This hypothesis is now well supported in the
recent paper by Henry and Campbell (1998). Embryoid or laminin-2 (Talts et al., 1999). Thus, dystroglycan may
bind to both laminin-1 and perlecan (Figure 2A), poten-bodies derived from dystroglycan knockout ES cells ap-
peared normal in most respects, but the subendodermal tially enhancing and organizing both heterophilic and
homophilic assembling interactions of these basementbasement membrane was severely disrupted. Laminin-1,
collagen type IV, and the proteoglycan perlecan showed membrane proteins with each other, and with collagen
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IV. Although both perlecan and laminin-1 may compete vital and highly dynamic process of basement mem-
brane assembly by multiple cell types.for the same a-dystroglycan binding site they differ inso-
Besides playing a role in basement membrane assem-far as laminin-1 binding is inhibited by heparin, whereas
bly, a-dystroglycan is also a specific receptor for severalperlecan binding is not. Presumably both of these li-
arenaviruses (Figure 2B). Cao and colleagues (1998)gands bind to O-linked carbohydrate sites on dystrogly-
have demonstrated that lymphocytic choriomeningitiscan, but the precise structural details remain to be deter-
virus (LCMV), lassa fever virus (LFV), and two othermined. As indicated in Figure 2A, an isoform of agrin (that
arenaviruses bound to purified a-dystroglycan, whereasdoes not cluster AChR) is present in several nonmuscle
soluble a-dystroglycan (at only 0.9 nM concentration)tissues, such as lung, kidney, and brain, where it may
blocked LCMV infection of target cells. Furthermore,also bind strongly to dystroglycan (Gesemann et al.,
a-dystroglycan knockout ES cells failed to become in-1998). It seems likely that this nonmuscle agrin might
fected with LCMV, but were readily infected whenalso participate in dystroglycan-regulated basement
a-dystroglycan was reconstituted. The LCMV interactedmembrane assembly, but this has not yet been demon-
with purified a-dystroglycan that had been subjectedstrated.
to denaturing SDS-PAGE, but failed to interact withBecause proteins in the sarcoglycan complex (a, b,
a-dystroglycan fusion proteins produced in E. coli.g, d sarcoglycan, sarcospan) are largely restricted to
These results suggest that a posttranslational modifica-muscle, epithelial dystroglycan is predicted to lack these
tion, such as glycosylation, is critical. Earlier work hadpartners, while having fewer partners, or perhaps differ-
shown that N-linked sugars may not be involved in virusent transmembrane partners that have not yet been dis-
binding. However, if the arenavirus binding site is similarcovered. Also in epithelial cells, the dystroglycan cy-
to the laminin site on a-dystroglycan, it may requiretoskeletal connections involve various dystrophin family
O-linked sugars. In future experiments it will be interest-members other than dystrophin itself. It seems likely
ing to see if, like laminin and perlecan binding, virusthat associated dystrophin family members should be
binding is indeed glycosylation dependent, and/or diva-critical for facilitating dystroglycan-dependent ECM as-
lent cation dependent, and if there is any competitionsembly, but this has yet to be demonstrated. As seen
between arenavirus and proteins containing laminin-previously for integrin-dependent assembly of fibronec-
type LG domains. The broad specificity of arenavirus istin extracellular matrices (Wu et al., 1995), cytoskeletal
consistent with the wide distribution of a-dystroglycan.connections should play an essential role. If alterations
It remains to be determined whether virus induces re-in key dystroglycan-associated proteins lead to pertur-
ceptor clustering, and whether that might be part of thebation of the basement membrane organizing properties
infection mechanism. Also, it is not clear which, if any,of dystroglycan, this may help to explain some of the
dystroglycan-associated proteins may be also involvedabnormalities in the heart, diaphragm, and peripheral
in arenavirus infection. In this regard, virus receptor con-and central nervous systems that are associated with
nection to actin microfilaments may not be critical formuscular dystrophy.
virus uptake (Borrow and Oldstone, 1994). While identifi-Until recently, b1 integrins were seen as perhaps the
cation of a-dystroglycan as a receptor for arenavirus isprimary cell surface regulators of basement membrane
only the first step, it nonetheless represents an impor-assembly (Sasaki et al., 1998; Schwarzbauer, 1999). Now
tant step toward intervention in the fatal human hemor-that dystroglycan has also emerged as a major player,
ragic fevers caused by arenaviruses.several striking parallels may be noted (Schwarzbauer,
Another pathological role for dystroglycan has also1999). First, the b1 integrins, like dystroglycan, bind to
emerged (Figure 2C). Previously, Rambukkana and col-basement membrane components. b1 integrins bind not
leagues had utilized biochemical and genetic methodsonly to laminins, but also to collagens including collagen
to strongly implicate laminin-2 as a target for M. lepraeIV. Second, b1 integrins and dystroglycan both connect
infection of Schwann cells (Rambukkana et al., 1997).
to the actin cytoskeleton. Whereas dystroglycan binds
At that time, partial antibody blocking effects led to
to actin filaments through dystrophin, integrins utilize
the suggestion that the a6b4 integrin was possibly the
talin, a-actinin, and/or filamin to connect to actin. In Schwann cell receptor for M. leprae complexed with
both cases connection to the actin cytoskeleton is pre- laminin-2. In their most recent study, Rambukkana and
dicted to provide the tension necessary for basement coworkers now provide data pointing strongly to a-dys-
membrane assembly. Furthermore, just as embryoid troglycan as a key Schwann cell receptor for M. leprae
bodies derived from dystroglycan-null ES cells showed (Rambukkana et al., 1998). M. leprae binding to purified
a disrupted basement membrane (see above), terato- a-dystroglycan and to Schwann cell a-dystroglycan was
mas derived from b1-deficient ES cells also showed almost entirely dependent on laminin-2. Interestingly,
markedly aberrant basement membrane assembly (Sa- the LG domain at the COOH terminus of the laminin-
saki et al., 1998). Interestingly, one recent comparative a2 chain contained both M. leprae and a-dystroglycan
antibody blocking study has revealed that exogenous binding activity, and a recombinant form of this region
laminin polymerization by C2C12 myoblasts was sup- alone was sufficient to link the bacteria to the a-dystro-
ported much more by dystroglycan than by b1 integrins. glycan.
Nonetheless, laminin polymerization (but not simply Consistent with laminin-2 binding results reviewed
laminin-binding) induced the reorganization of both b1 elsewhere (Durbeej et al., 1998), binding of M. leprae±
integrin (a7b1) and dystroglycan into overlapping net- laminin-2 LG domain complexes to a-dystroglycan is
works (Colognato et al., 1999). In future studies it will likely dependent on a-dystroglycan glycosylation. Bind-
be important to examine further how dystroglycan may ing to a-dystroglycan, a highly glycosylated mucin-like
structure, was inhibited by periodate. Laminin-2 bindingwork together with integrins to initiate and maintain the
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Rambukkana, A., Yamada, H., Zanazzi, G., Mathus, T., Salzer, J.L.,was also completely inhibited by EDTA, consistent with
Yurchenco, P.D., Campbell, K.P., and Fischetti, V.A. (1998). Sciencea divalent cation-dependent lectin-like capability resid-
282, 2076±2079.ing in the LG-domain of laminin-2. Importantly, M. le-
Sasaki, T., Forsberg, E., Bloch, W., Addicks, K., FaÈ ssler, R., andprae±laminin complexes bound strongly to rat Schwann
Timpl, R. (1998). Exp. Cell Res. 238, 70±81.
cells that contained no b4 integrin. Because laminin-2
Schwarzbauer, J. (1999). Curr. Biol. 9, R242±R244.and a-dystroglycan are not restricted to Schwann cells,
Talts, J.F., Andac, Z., Gohring, W., Brancaccio, A., and Timpl, R.it remains unclear why M. leprae has specificity for
(1999). EMBO J. 18, 863±870.
Schwann cells. Possibly other laminin receptors could
Timpl, R., and Brown, J.C. (1996). Bioessays 18, 123±132.help to provide specificity, or a-dystroglycan on Schwann
Williamson, R.A., Henry, M.D., Daniels, K.J., Hrstka, R.F., Lee, J.C.,cells could be associated with other proteins that
Sunada, Y., Ibraghimov-Beskrovnaya, O., and Campbell, K.P. (1997).
provide specificity for bacterial binding and/or uptake. Hum. Mol. Genet. 6, 831±841.
In the Schwann cell membrane, dystroglycan may Wu, C., Kevins, V., O'Toole, T.E., McDonald, J.A., and Ginsberg,
be linked to dystrophin family members utrophin and M.H. (1995). Cell 83, 715±724.
Dp116, with sarcoglycan-type proteins being absent,
or yet to be identified. Presumably these dystroglycan-
associated proteins, with their link to cytoskeleton, could
assist in bacterial uptake. Agrin also binds strongly to
dystroglycan on Schwann cells, but the role of agrin in
M. leprae infection has not yet been addressed.
In summary, functions of dystroglycan outside of the
muscle arena are becoming increasingly apparent. It is
now clear that in a variety of tissues and cell types,
a- and b-dystroglycan complexes provide a critical link
between multiple extracellular matrix proteins and the
actin cytoskeleton, and play a key role in the assembly
of extracellular matrix. In these areas, dystroglycan may
provide an important complement to the role of inte-
grins. Also, dystroglycan has been usurped by two types
of pathogens, to provide an entry for cellular infection.
With its capability to bind to a range of distinct ECM
proteins, and with its variable associations with a num-
ber of distinct transmembrane and cytoskeletal pro-
teins, dystroglycan plays a central role in organizing
protein complexes with substantial functional flexibility.
The next challenge will be to identify and sort out the
still unknown components present in each of the distinct
dystroglycan complexes, and to determine how these
components work together to provide a range of specific
functions in various normal and pathologic processes.
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